Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 13.09.2022.

#biotech
#lifesciences
#2022IndustryReport
#VCs
#AI
#ML
#startups
#NBTNewsBeat
#IPO
#Incubators

@GVteam shared
On Sep 7, 2022
Thanks to @BusinessInsider for shining a light on Boston’s venture capital ecosystem and the work of @brobbs, @schenkein, and @kyeshwant — https://t.co/FR0AkltxtI
Open
The 41 most important VCs in Boston, according to other VCs

The 41 most important VCs in Boston, according to other VCs

The greater Boston area claims a number of savvy, if under-the-radar, investors as residents. We asked VCs about the ones to know.

@PitchBook shared
On Sep 11, 2022
💡 According to our data, #AI and #ML technologies have drawn increased funding in recent years, including a surge last year when #VCs globally invested some $115 billion in the space. Our data helped inform this piece from @BusinessInsider 🔽 https://t.co/oFQObAv51O
Open
6 AI startups and the pitch decks they used to raise funding from investors like Goldman Sachs, Tiger Global, and Microsoft's M12

6 AI startups and the pitch decks they used to raise funding from investors like Goldman Sachs, Tiger Global, and Microsoft's M12

AI has drawn increased funding and interest from investors in recent years. Last year, AI startups raised $115 billion, according to PitchBook data.

@GVteam shared
On Sep 12, 2022
Welcome Pretzel Therapeutics to the portfolio 🎉 Pretzel Therapeutics is developing groundbreaking therapies based on a deep mechanistic understanding of mitochondrial biology — https://t.co/DObCAjJEEY
Open
Mitochondrial drugs, with a twist: Pretzel Therapeutics launches with $72.5M in funding

Mitochondrial drugs, with a twist: Pretzel Therapeutics launches with $72.5M in funding

Scientists at Pretzel believe fixing mutated mitochondrial DNA with a mix of small molecule therapies and gene editing could be key to solving a number of hard-to-treat diseases.

@MALifeSciences shared
On Sep 12, 2022
RT @MassBio: No one could have predicted how a global pandemic would impact much of anything, let alone the #lifesciences ecosystem in the US. Our #2022IndustryReport documents the biopharma industry in Mass. is in no way losing its mojo as a life sciences powerhouse. https://t.co/1qqArEkoeq https://t.co/HDxfhMWOIm
Open
After reset, Massachusetts life sciences ecosystem continues to regionalize and expand

After reset, Massachusetts life sciences ecosystem continues to regionalize and expand

No one could have predicted how a global pandemic would impact much of anything, let alone the life sciences ecosystem in the United States. Though COVID-19 certainly at times kept ...

@NatureBiotech shared
On Sep 13, 2022
.@POTUS Joe Biden launches a National Biotechnology and Biomanufacturing Initiative to create jobs, build stronger supply chains and ensure US global leadership in biotech #NBTNewsBeat via @whitehouse https://t.co/pmqWAxmBFt
Open
Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy

Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered as follows: Section 1.

@BentheFidler shared
On Sep 13, 2022
RT @a_silverstein: .@3rdHarmonicBio may signal #biotech IPOs can bounce back. Unlike many 2021 IPOs, the company is in the clinic. More analysis her from @BentheFidler for @BioPharmaDive https://t.co/3CtF68GGTg
Open
Can biotech IPOs bounce back? Third Harmonic to test investor appetite with planned offering

Can biotech IPOs bounce back? Third Harmonic to test investor appetite with planned offering

The startup is the first young drugmaker in more than four months to seek an IPO of at least $100 million, a once common occurrence that's become rare following this year's sector-wide ...

@BusinessInsider shared
On Sep 12, 2022
How an institute at the University of Utah has helped entrepreneurs build their startups and raise more than $700 million in funding. Presented by @SiemensUSA. https://t.co/UE5hUwOlzv
Open
How an institute at the University of Utah has helped entrepreneurs build their startups and raise more than $700 million in funding

How an institute at the University of Utah has helped entrepreneurs build their startups and raise more than $700 million in funding

The Lassonde Entrepreneur Institute has helped current and former students start more than 2,700 businesses with financial support and mentorship.

@big4bio shared
On Sep 12, 2022
RT @BiotechnologyPa: Philly Builds BIO+ is hosting its Inaugural Symposium for Life Science Innovation and Development on Sept 13. PABC President @lou_kassa will moderate the panel on Accelerators and #Incubators. Register & learn more here: https://t.co/YNgJzwgcis https://t.co/mmKR0qJuHe
Open
Inaugural Symposium for Life Science Innovation and Development

Inaugural Symposium for Life Science Innovation and Development

Philly Builds BIO+ Symposium brings Philadelphia's life science and real estate communities together on Sep 13, 2022 in The Union League.